Works matching IS 0741238X AND DT 2025 AND VI 42 AND IP 1
Results: 41
Correction to: Indirect Treatment Comparisons in Healthcare Decision Making: A Targeted Review of Regulatory Approval, Reimbursement, and Pricing Recommendations Globally for Oncology Drugs in 2021–2023.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Patient Satisfaction Scale Following a Laxative for Antibiotic Washout Prior to Oral Microbiome Therapy.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 490, doi. 10.1007/s12325-024-03065-8
- By:
- Publication type:
- Article
Correction to: Effcacy of Ixekizumab in Chinese Patients with Moderate-to-Severe Psoriasis and Special Body Area Involvement: Sub-analysis of a Randomized, Double-Blind, Multicenter Phase 3 Study.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Integrating Genetic Insights, Technological Advancements, Screening, and Personalized Pharmacological Interventions in Childhood Obesity.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 72, doi. 10.1007/s12325-024-03057-8
- By:
- Publication type:
- Article
Secondary Risk-Reducing Strategies for Contralateral Breast Cancer in BRCA1/2 Variant Carriers: A Systematic Review and Meta-analysis.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 106, doi. 10.1007/s12325-024-03054-x
- By:
- Publication type:
- Article
Predicting Asthma Exacerbations Using Machine Learning Models.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 362, doi. 10.1007/s12325-024-03053-y
- By:
- Publication type:
- Article
Drug Survival, Retention, and Persistence of Dupilumab in Adults and Adolescents with Atopic Dermatitis: A Narrative Literature Review.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 94, doi. 10.1007/s12325-024-03052-z
- By:
- Publication type:
- Article
Investigation of Severe Hypoglycemia Risk Among Patients with Diabetes Treated with Ultra-Rapid Lispro in Japan.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 413, doi. 10.1007/s12325-024-03050-1
- By:
- Publication type:
- Article
Real-World Safety and Effectiveness of Dimethyl Fumarate in Patients with MS: Results from the ESTEEM Phase 4 and PROCLAIM Phase 3 Studies with a Focus on Older Patients.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 395, doi. 10.1007/s12325-024-03047-w
- By:
- Publication type:
- Article
Utility of Loneliness Status to Risk Stratification and Prediction of Recurrent Atrial Fibrillation After Catheter Ablation.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 456, doi. 10.1007/s12325-024-03046-x
- By:
- Publication type:
- Article
A Response to: Letter to the Editor Regarding "Comparing Cardiovascular Outcomes and Costs of Perindopril-, Enalapril- or Losartan-Based Antihypertensive Regimens in South Africa: Real-World Medical Claims Database Analysis".
- Published in:
- 2025
- By:
- Publication type:
- Letter
Assessment of Phosphorodiamidate Morpholino Oligomer Treatment Patterns for Patients with Duchenne Muscular Dystrophy: A MarketScan Claims Analysis.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 523, doi. 10.1007/s12325-024-03044-z
- By:
- Publication type:
- Article
Using Chronic Kidney Disease as a Model Framework to Estimate Healthcare-Related Environmental Impact.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 348, doi. 10.1007/s12325-024-03039-w
- By:
- Publication type:
- Article
Predictors for Irreversibility of Contrast-Induced Acute Kidney Injury in Patients with Obesity After Contrast-Enhanced Computed Tomography Coronary Angiography.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 293, doi. 10.1007/s12325-024-03036-z
- By:
- Publication type:
- Article
Cost-Effectiveness of Vibrant System vs. Linaclotide in Chronic Idiopathic Constipation.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 310, doi. 10.1007/s12325-024-03035-0
- By:
- Publication type:
- Article
Comparative Effectiveness of Biologic Classes in Clinical Practice: Month 12 Outcomes from the International Observational Psoriasis Study of Health Outcomes (PSoHO).
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 233, doi. 10.1007/s12325-024-03034-1
- By:
- Publication type:
- Article
Cost-Effectiveness of Trastuzumab Deruxtecan in Patients with Unresectable or Metastatic HER2-Low Breast Cancer Who Have Received Prior Chemotherapy.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 322, doi. 10.1007/s12325-024-03033-2
- By:
- Publication type:
- Article
Efanesoctocog Alfa versus Standard and Extended Half-Life Factor VIII Prophylaxis in Adolescent and Adult Patients with Haemophilia A without Inhibitors.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 427, doi. 10.1007/s12325-024-03032-3
- By:
- Publication type:
- Article
Efanesoctocog Alfa Versus Emicizumab in Adolescent and Adult Patients With Haemophilia A Without Inhibitors.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 442, doi. 10.1007/s12325-024-03031-4
- By:
- Publication type:
- Article
Efficacy and Safety Analysis in Chinese Patients with Moderate-to-Severe Psoriasis from a Phase 3 Trial: Impact of Treatment Withdrawal and Retreatment of Ixekizumab.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 334, doi. 10.1007/s12325-024-03030-5
- By:
- Publication type:
- Article
Prognostic Impact of Neutropenia Recovery and G-CSF Use in Onco-Hematological Neutropenic Patients Admitted to Intensive Care Unit for Acute Respiratory Failure: A Retrospective, Real World Analysis.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 280, doi. 10.1007/s12325-024-03029-y
- By:
- Publication type:
- Article
Clinical Characteristics and Treatment of Patients Diagnosed with Pulmonary Arterial Hypertension: A Real-World Study in the USA, Europe and Japan.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 193, doi. 10.1007/s12325-024-03026-1
- By:
- Publication type:
- Article
Letter to the Editor Regarding "Comparing Cardiovascular Outcomes and Costs of Perindopril-, Enalapril- or Losartan-Based Antihypertensive Regimens in South Africa: Real-World Medical Claims Database Analysis".
- Published in:
- 2025
- By:
- Publication type:
- Letter
Oral Corticosteroid-Related Healthcare Resource Utilization and Associated Costs in Patients with COPD.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 375, doi. 10.1007/s12325-024-03024-3
- By:
- Publication type:
- Article
Therapeutic Applications for Homeopathy in Clinical Practice.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 36, doi. 10.1007/s12325-024-03022-5
- By:
- Publication type:
- Article
Understanding Influenza Vaccine Clinical Performance: A Podcast.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 1, doi. 10.1007/s12325-024-03021-6
- By:
- Publication type:
- Article
Sacral and Implantable Tibial Neuromodulation for the Management of Overactive Bladder: A Systematic Review and Meta-analysis.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 10, doi. 10.1007/s12325-024-03019-0
- By:
- Publication type:
- Article
A Phase 1 Randomized, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Enteric-Coated Stabilized Sulforaphane (SFX-01) in Male Participants.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 216, doi. 10.1007/s12325-024-03018-1
- By:
- Publication type:
- Article
Our Experience in Treating Infantile Hemangioma: Prognostic Factors for Relapse After Propranolol Discontinuation.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 537, doi. 10.1007/s12325-024-03017-2
- By:
- Publication type:
- Article
Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Dialysis-Dependent Patients with Anaemia of Chronic Kidney Disease: A Retrospective Observational Study.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 471, doi. 10.1007/s12325-024-03015-4
- By:
- Publication type:
- Article
Indirect Treatment Comparisons in Healthcare Decision Making: A Targeted Review of Regulatory Approval, Reimbursement, and Pricing Recommendations Globally for Oncology Drugs in 2021–2023.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 52, doi. 10.1007/s12325-024-03013-6
- By:
- Publication type:
- Article
Correction to: Inside ANEMIA of CKD: Projecting the Future Burden of Anemia of Chronic Kidney Disease and Benefits of Proactive Management: A Microsimulation Model of the Chinese Population.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Correction to: Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis: Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Monotherapy Trials (ADvocate1 and ADvocate2).
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Effect of Cariprazine on Anhedonia in Patients with Bipolar I Depression: Post Hoc Analysis of Three Randomized Placebo-Controlled Clinical Trials.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 246, doi. 10.1007/s12325-024-03009-2
- By:
- Publication type:
- Article
Endoscopic Minimally Invasive Approach Versus Median Sternotomy for Multiple-Valve Surgery: A Propensity-Matched Analysis.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 261, doi. 10.1007/s12325-024-03008-3
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of Pharmaceutical-Grade Chondroitin Sulfate for Knee Osteoarthritis Based on Individual Patient Data from a Randomized Clinical Trial.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 165, doi. 10.1007/s12325-024-03007-4
- By:
- Publication type:
- Article
Effect of Tezepelumab on Sino-Nasal Outcome Test (SNOT)-22 Domain and Symptom-Specific Scores in Patients with Severe, Uncontrolled Asthma and a History of Chronic Rhinosinusitis with Nasal Polyps.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 510, doi. 10.1007/s12325-024-03006-5
- By:
- Publication type:
- Article
Dosing Patterns of Dulaglutide and Semaglutide in Patients with Type 2 Diabetes Mellitus in France and Italy: A Retrospective Cohort Study.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 174, doi. 10.1007/s12325-024-03002-9
- By:
- Publication type:
- Article
A Retrospective Claims Analysis of the Rate of Complications in Patients Undergoing Treatment for Paroxysmal Nocturnal Hemoglobinuria.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 500, doi. 10.1007/s12325-024-03001-w
- By:
- Publication type:
- Article
Efficacy of Ixekizumab in Chinese Patients with Moderate-to-Severe Psoriasis and Special Body Area Involvement: Sub-analysis of a Randomized, Double-Blind, Multicenter Phase 3 Study.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 146, doi. 10.1007/s12325-024-02976-w
- By:
- Publication type:
- Article
Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis: Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Monotherapy Trials (ADvocate1 and ADvocate2).
- Published in:
- Advances in Therapy, 2025, v. 42, n. 1, p. 132, doi. 10.1007/s12325-024-02974-y
- By:
- Publication type:
- Article